Rare tumors, rare dilemmas: When evidence runs out, ethics begins
When talking about cancer care, we often assume that clinical decisions are guided by strong evidence and clear guidelines. But for patients with rare tumors,
Read More
When talking about cancer care, we often assume that clinical decisions are guided by strong evidence and clear guidelines. But for patients with rare tumors,
Read More